C.K. Cooper downgraded shares of Durect Corp. (NASDAQ: DRRX) from a buy rating to a hold rating in a report issued on Thursday. They currently have $3.00 target price on the stock.
Shares of Durect Corp. traded down 35.88% during mid-day trading on Thursday, hitting $0.8784. Durect Corp. has a 52 week low of $0.68 and a 52 week high of $1.71. The company has a market cap of $77.0 million and a P/E ratio of 6.34.
Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on the drug delivery technology platforms.